TENJ BIOTECH ApS: Financial statements 2019
CVR: 35243798
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
TENJ BIOTECH ApS (CVR 35243798) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -16,230 and a net result of DKK -16,230 compared with DKK -1,228 the year before. Equity in the 2019 report amounted to DKK 145,204. The solvency ratio was 16.4%.
- Gross Profit
- DKK -16,230
- Profit/Loss
- DKK -16,230
- Equity
- DKK 145,204
- Total Assets
- DKK 885,329
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -16 t. | -16 t. | 145 t. | - |
| 2018 | - | -16 t. | -1 t. | 161 t. | - |
| 2017 | - | -16 t. | -16 t. | 163 t. | - |
| 2016 | - | -21 t. | 3.4 mio. | 179 t. | - |
| 2015 | - | - | -14 t. | 27 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
TENJ BIOTECH ApS has published its annual report for 2018. Gross profit came to DKK -16,225, and the net result was DKK -1,228.
About TENJ BIOTECH ApS
TENJ BIOTECH ApS was a Danish company of the type Anpartsselskab based in Holte, founded in 2013. The company has been dissolved on 2 December 2020. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2019, the company reported a gross profit of DKK -16,230 and a net result of DKK -16,230 compared with DKK -1,228 the year before. Equity in the 2019 report amounted to DKK 145,204.